APA

Santacana E., Rodríguez-Alonso L., Padullés A., Guardiola J., Bas J., Rodríguez-Moranta F., Serra K., Morandeira F., Colom H. & Padullés N. (20210428). Predictors of Infliximab Trough Concentrations in Inflammatory Bowel Disease Patients Using a Repeated-Measures Design. : Therapeutic drug monitoring.

Chicago

Santacana Eugènia, Rodríguez-Alonso Lorena, Padullés Ariadna, Guardiola Jordi, Bas Jordi, Rodríguez-Moranta Francisco, Serra Katja, Morandeira Francisco, Colom Helena and Padullés Núria. 20210428. Predictors of Infliximab Trough Concentrations in Inflammatory Bowel Disease Patients Using a Repeated-Measures Design. : Therapeutic drug monitoring.

Harvard

Santacana E., Rodríguez-Alonso L., Padullés A., Guardiola J., Bas J., Rodríguez-Moranta F., Serra K., Morandeira F., Colom H. and Padullés N. (20210428). Predictors of Infliximab Trough Concentrations in Inflammatory Bowel Disease Patients Using a Repeated-Measures Design. : Therapeutic drug monitoring.

MLA

Santacana Eugènia, Rodríguez-Alonso Lorena, Padullés Ariadna, Guardiola Jordi, Bas Jordi, Rodríguez-Moranta Francisco, Serra Katja, Morandeira Francisco, Colom Helena and Padullés Núria. Predictors of Infliximab Trough Concentrations in Inflammatory Bowel Disease Patients Using a Repeated-Measures Design. : Therapeutic drug monitoring. 20210428.